BioLineRx Ltd.
BLRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $683,720 | $4,033,290 | $1,217,692 | $3,606,359 |
| - Cash | $10,436 | $4,255 | $10,587 | $12,990 |
| + Debt | $15,040 | $11,591 | $12,324 | $4,651 |
| Enterprise Value | $688,324 | $4,040,626 | $1,219,429 | $3,598,020 |
| Revenue | $28,940 | $4,800 | $0 | $0 |
| % Growth | 502.9% | – | – | – |
| Gross Profit | $19,677 | $1,108 | $0 | $0 |
| % Margin | 68% | 23.1% | – | – |
| EBITDA | $3,918 | -$57,086 | -$28,503 | -$24,074 |
| % Margin | 13.5% | -1,189.3% | – | – |
| Net Income | -$9,221 | -$60,614 | -$24,951 | -$27,054 |
| % Margin | -31.9% | -1,262.8% | – | – |
| EPS Diluted | -0.12 | -0.94 | -0.48 | -0.61 |
| % Growth | 87.2% | -95.8% | 21.3% | – |
| Operating Cash Flow | -$43,873 | -$22,608 | -$26,240 | -$23,573 |
| Capital Expenditures | -$54 | -$297 | -$316 | -$97 |
| Free Cash Flow | -$43,927 | -$22,905 | -$26,556 | -$23,670 |